The private insurance companies running MA have never delivered health care at a lower cost than traditional Medicare.
They said, 'Hand it over to us, and we will do this cheaper.'
I have confidence in the FDA staff, who rely on the best available scientific evidence to determine the safety and effectiveness of drugs.
Taking mifepristone off the market would significantly compromise access across the country.
the government step in to manufacture generic drugs when products have small market sizes and large drug price increases.
I urge CMS to finalize this proposal.
So they will go up. CMS is proposing to increase payments to MA plans next year.
The Biden-Harris administration is committed to protecting access to reproductive health care.